Rui De Biologics' Corporate Majority Round

Rui De Biologics raised a round of funding on June 13, 2017. Investors include CSL.

Rui De Biologics (武汉中原瑞德生物制品有限责任公司) develops, manufactures and commercializes plasma-derived products for the Chinese domestic market.…

Articles about Rui De Biologics' Corporate Majority Round: